201620172018201920202021202220232024Billable/Specific Code
- I88.8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM I88.8 became effective on October 1, 2022.
- This is the American ICD-10-CM version of I88.8 – other international versions of ICD-10 I88.8 may differ.
ICD-10-CM I88.8 is grouped within Diagnostic Related Group(s):
- 814 Reticuloendothelial and immunity disorders with mcc
- 815 Reticuloendothelial and immunity disorders with cc
- 816 Reticuloendothelial and immunity disorders without cc/mcc
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to I88.8:
- indolent (nonspecific) > Bubo I88.8
- inguinal (nonspecific) > Bubo I88.8
- infective > inguinal (nonspecific) I88.8
- gland (lymph) > Granuloma L92.9
- regional, nonbacterial > Lymphadenitis I88.9